 | • レポートコード：QFJ1-3887 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細菌性膣炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科手術治療、薬物治療）、用途別市場規模（病院、専門治療センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細菌性膣炎治療の市場動向 ・企業の競争状況、市場シェア ・細菌性膣炎治療の種類別市場規模と予測2016-2027（外科手術治療、薬物治療） ・細菌性膣炎治療の用途別市場規模と予測2016-2027（病院、専門治療センター、その他） ・細菌性膣炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・細菌性膣炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細菌性膣炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細菌性膣炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・細菌性膣炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Pfizer、Lupin Inc、Merck、Sanofi、Piramal、Abbott、Galderma、Mission、Alkem、Xiuzheng、Teva、Perrigo、West-Ward、HPGC、Yunnan Baiyao、Starpharma、Novel、Edenvridge） ・結論 |
Bacterial vaginosis (BV) is a common vaginal infection.Is one of the most widely studied obstetric/gynecological infectious diseases.An infection associated with a group of pathogenic anaerobic microorganisms rather than a specific pathogen.This includes surgery and medication.Bacterial vaginosis is treated with oral and local treatment by detecting odor, clue cells and alkalinity of secretions.
Market Analysis and Insights: Global Bacterial Vaginosis Treatment Market
The global Bacterial Vaginosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacterial Vaginosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacterial Vaginosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacterial Vaginosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacterial Vaginosis Treatment market.
Global Bacterial Vaginosis Treatment Scope and Market Size
Bacterial Vaginosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical Treatment
Drug Treatment
Segment by Application
Hospital
Specialist Treatment Centre
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer
Pfizer
Lupin Inc
Merck
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacterial Vaginosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Treatment
1.2.3 Drug Treatment
1.3 Market by Application
1.3.1 Global Bacterial Vaginosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialist Treatment Centre
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Vaginosis Treatment Market Perspective (2016-2027)
2.2 Bacterial Vaginosis Treatment Growth Trends by Regions
2.2.1 Bacterial Vaginosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacterial Vaginosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bacterial Vaginosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bacterial Vaginosis Treatment Industry Dynamic
2.3.1 Bacterial Vaginosis Treatment Market Trends
2.3.2 Bacterial Vaginosis Treatment Market Drivers
2.3.3 Bacterial Vaginosis Treatment Market Challenges
2.3.4 Bacterial Vaginosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Vaginosis Treatment Players by Revenue
3.1.1 Global Top Bacterial Vaginosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Bacterial Vaginosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bacterial Vaginosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacterial Vaginosis Treatment Revenue
3.4 Global Bacterial Vaginosis Treatment Market Concentration Ratio
3.4.1 Global Bacterial Vaginosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Treatment Revenue in 2020
3.5 Bacterial Vaginosis Treatment Key Players Head office and Area Served
3.6 Key Players Bacterial Vaginosis Treatment Product Solution and Service
3.7 Date of Enter into Bacterial Vaginosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacterial Vaginosis Treatment Breakdown Data by Type
4.1 Global Bacterial Vaginosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bacterial Vaginosis Treatment Forecasted Market Size by Type (2022-2027)
5 Bacterial Vaginosis Treatment Breakdown Data by Application
5.1 Global Bacterial Vaginosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bacterial Vaginosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bacterial Vaginosis Treatment Market Size (2016-2027)
6.2 North America Bacterial Vaginosis Treatment Market Size by Type
6.2.1 North America Bacterial Vaginosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Bacterial Vaginosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Bacterial Vaginosis Treatment Market Size by Type (2016-2027)
6.3 North America Bacterial Vaginosis Treatment Market Size by Application
6.3.1 North America Bacterial Vaginosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Bacterial Vaginosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Bacterial Vaginosis Treatment Market Size by Application (2016-2027)
6.4 North America Bacterial Vaginosis Treatment Market Size by Country
6.4.1 North America Bacterial Vaginosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Bacterial Vaginosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bacterial Vaginosis Treatment Market Size (2016-2027)
7.2 Europe Bacterial Vaginosis Treatment Market Size by Type
7.2.1 Europe Bacterial Vaginosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bacterial Vaginosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bacterial Vaginosis Treatment Market Size by Type (2016-2027)
7.3 Europe Bacterial Vaginosis Treatment Market Size by Application
7.3.1 Europe Bacterial Vaginosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bacterial Vaginosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bacterial Vaginosis Treatment Market Size by Application (2016-2027)
7.4 Europe Bacterial Vaginosis Treatment Market Size by Country
7.4.1 Europe Bacterial Vaginosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bacterial Vaginosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bacterial Vaginosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type
8.2.1 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application
8.3.1 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Region
8.4.1 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacterial Vaginosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bacterial Vaginosis Treatment Market Size (2016-2027)
9.2 Latin America Bacterial Vaginosis Treatment Market Size by Type
9.2.1 Latin America Bacterial Vaginosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bacterial Vaginosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bacterial Vaginosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Bacterial Vaginosis Treatment Market Size by Application
9.3.1 Latin America Bacterial Vaginosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bacterial Vaginosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bacterial Vaginosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Bacterial Vaginosis Treatment Market Size by Country
9.4.1 Latin America Bacterial Vaginosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bacterial Vaginosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacterial Vaginosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type
10.2.1 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application
10.3.1 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Country
10.4.1 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacterial Vaginosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Bacterial Vaginosis Treatment Introduction
11.1.4 Bayer Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bacterial Vaginosis Treatment Introduction
11.2.4 Pfizer Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Lupin Inc
11.3.1 Lupin Inc Company Details
11.3.2 Lupin Inc Business Overview
11.3.3 Lupin Inc Bacterial Vaginosis Treatment Introduction
11.3.4 Lupin Inc Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.3.5 Lupin Inc Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Bacterial Vaginosis Treatment Introduction
11.4.4 Merck Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Bacterial Vaginosis Treatment Introduction
11.5.4 Sanofi Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Piramal
11.6.1 Piramal Company Details
11.6.2 Piramal Business Overview
11.6.3 Piramal Bacterial Vaginosis Treatment Introduction
11.6.4 Piramal Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.6.5 Piramal Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Bacterial Vaginosis Treatment Introduction
11.7.4 Abbott Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Galderma
11.8.1 Galderma Company Details
11.8.2 Galderma Business Overview
11.8.3 Galderma Bacterial Vaginosis Treatment Introduction
11.8.4 Galderma Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.8.5 Galderma Recent Development
11.9 Mission
11.9.1 Mission Company Details
11.9.2 Mission Business Overview
11.9.3 Mission Bacterial Vaginosis Treatment Introduction
11.9.4 Mission Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.9.5 Mission Recent Development
11.10 Alkem
11.10.1 Alkem Company Details
11.10.2 Alkem Business Overview
11.10.3 Alkem Bacterial Vaginosis Treatment Introduction
11.10.4 Alkem Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.10.5 Alkem Recent Development
11.11 Xiuzheng
11.11.1 Xiuzheng Company Details
11.11.2 Xiuzheng Business Overview
11.11.3 Xiuzheng Bacterial Vaginosis Treatment Introduction
11.11.4 Xiuzheng Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.11.5 Xiuzheng Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Bacterial Vaginosis Treatment Introduction
11.12.4 Teva Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.12.5 Teva Recent Development
11.13 Perrigo
11.13.1 Perrigo Company Details
11.13.2 Perrigo Business Overview
11.13.3 Perrigo Bacterial Vaginosis Treatment Introduction
11.13.4 Perrigo Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.13.5 Perrigo Recent Development
11.14 West-Ward
11.14.1 West-Ward Company Details
11.14.2 West-Ward Business Overview
11.14.3 West-Ward Bacterial Vaginosis Treatment Introduction
11.14.4 West-Ward Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.14.5 West-Ward Recent Development
11.15 HPGC
11.15.1 HPGC Company Details
11.15.2 HPGC Business Overview
11.15.3 HPGC Bacterial Vaginosis Treatment Introduction
11.15.4 HPGC Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.15.5 HPGC Recent Development
11.16 Yunnan Baiyao
11.16.1 Yunnan Baiyao Company Details
11.16.2 Yunnan Baiyao Business Overview
11.16.3 Yunnan Baiyao Bacterial Vaginosis Treatment Introduction
11.16.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.16.5 Yunnan Baiyao Recent Development
11.17 Starpharma
11.17.1 Starpharma Company Details
11.17.2 Starpharma Business Overview
11.17.3 Starpharma Bacterial Vaginosis Treatment Introduction
11.17.4 Starpharma Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.17.5 Starpharma Recent Development
11.18 Novel
11.18.1 Novel Company Details
11.18.2 Novel Business Overview
11.18.3 Novel Bacterial Vaginosis Treatment Introduction
11.18.4 Novel Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
11.18.5 Novel Recent Development
11.18 Edenvridge
.1 Edenvridge Company Details
.2 Edenvridge Business Overview
.3 Edenvridge Bacterial Vaginosis Treatment Introduction
.4 Edenvridge Revenue in Bacterial Vaginosis Treatment Business (2016-2021)
.5 Edenvridge Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bacterial Vaginosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Treatment
Table 3. Key Players of Drug Treatment
Table 4. Global Bacterial Vaginosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bacterial Vaginosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bacterial Vaginosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bacterial Vaginosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Bacterial Vaginosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bacterial Vaginosis Treatment Market Share by Regions (2022-2027)
Table 10. Bacterial Vaginosis Treatment Market Trends
Table 11. Bacterial Vaginosis Treatment Market Drivers
Table 12. Bacterial Vaginosis Treatment Market Challenges
Table 13. Bacterial Vaginosis Treatment Market Restraints
Table 14. Global Bacterial Vaginosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bacterial Vaginosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Bacterial Vaginosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Treatment as of 2020)
Table 17. Ranking of Global Top Bacterial Vaginosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bacterial Vaginosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bacterial Vaginosis Treatment Product Solution and Service
Table 21. Date of Enter into Bacterial Vaginosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bacterial Vaginosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Bacterial Vaginosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bacterial Vaginosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bacterial Vaginosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bacterial Vaginosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Bacterial Vaginosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bacterial Vaginosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bacterial Vaginosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bacterial Vaginosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bacterial Vaginosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bacterial Vaginosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bacterial Vaginosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bacterial Vaginosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bacterial Vaginosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bacterial Vaginosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bacterial Vaginosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bacterial Vaginosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bacterial Vaginosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bacterial Vaginosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bacterial Vaginosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bacterial Vaginosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bacterial Vaginosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bacterial Vaginosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bacterial Vaginosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Bacterial Vaginosis Treatment Product
Table 64. Bayer Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Bacterial Vaginosis Treatment Product
Table 69. Pfizer Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Lupin Inc Company Details
Table 72. Lupin Inc Business Overview
Table 73. Lupin Inc Bacterial Vaginosis Treatment Product
Table 74. Lupin Inc Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Lupin Inc Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Bacterial Vaginosis Treatment Product
Table 79. Merck Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Bacterial Vaginosis Treatment Product
Table 84. Sanofi Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Piramal Company Details
Table 87. Piramal Business Overview
Table 88. Piramal Bacterial Vaginosis Treatment Product
Table 89. Piramal Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 90. Piramal Recent Development
Table 91. Abbott Company Details
Table 92. Abbott Business Overview
Table 93. Abbott Bacterial Vaginosis Treatment Product
Table 94. Abbott Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Abbott Recent Development
Table 96. Galderma Company Details
Table 97. Galderma Business Overview
Table 98. Galderma Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 99. Galderma Recent Development
Table 100. Mission Company Details
Table 101. Mission Business Overview
Table 102. Mission Bacterial Vaginosis Treatment Product
Table 103. Mission Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 104. Mission Recent Development
Table 105. Alkem Company Details
Table 106. Alkem Business Overview
Table 107. Alkem Bacterial Vaginosis Treatment Product
Table 108. Alkem Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 109. Alkem Recent Development
Table 110. Xiuzheng Company Details
Table 111. Xiuzheng Business Overview
Table 112. Xiuzheng Bacterial Vaginosis Treatment Product
Table 113. Xiuzheng Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 114. Xiuzheng Recent Development
Table 115. Teva Company Details
Table 116. Teva Business Overview
Table 117. Teva Bacterial Vaginosis Treatment Product
Table 118. Teva Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 119. Teva Recent Development
Table 120. Perrigo Company Details
Table 121. Perrigo Business Overview
Table 122. Perrigo Bacterial Vaginosis Treatment Product
Table 123. Perrigo Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 124. Perrigo Recent Development
Table 125. West-Ward Company Details
Table 126. West-Ward Business Overview
Table 127. West-Ward Bacterial Vaginosis Treatment Product
Table 128. West-Ward Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 129. West-Ward Recent Development
Table 130. HPGC Company Details
Table 131. HPGC Business Overview
Table 132. HPGC Bacterial Vaginosis Treatment Product
Table 133. HPGC Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 134. HPGC Recent Development
Table 135. Yunnan Baiyao Company Details
Table 136. Yunnan Baiyao Business Overview
Table 137. Yunnan Baiyao Bacterial Vaginosis Treatment Product
Table 138. Yunnan Baiyao Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 139. Yunnan Baiyao Recent Development
Table 140. Starpharma Company Details
Table 141. Starpharma Business Overview
Table 142. Starpharma Bacterial Vaginosis Treatment Product
Table 143. Starpharma Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 144. Starpharma Recent Development
Table 145. Novel Company Details
Table 146. Novel Business Overview
Table 147. Novel Bacterial Vaginosis Treatment Product
Table 148. Novel Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 149. Novel Recent Development
Table 150. Edenvridge Company Details
Table 151. Edenvridge Business Overview
Table 152. Edenvridge Bacterial Vaginosis Treatment Product
Table 153. Edenvridge Revenue in Bacterial Vaginosis Treatment Business (2016-2021) & (US$ Million)
Table 154. Edenvridge Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Vaginosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Bacterial Vaginosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Specialist Treatment Centre Case Studies
Figure 7. Other Case Studies
Figure 8. Bacterial Vaginosis Treatment Report Years Considered
Figure 9. Global Bacterial Vaginosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bacterial Vaginosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bacterial Vaginosis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Bacterial Vaginosis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Bacterial Vaginosis Treatment Market Share by Players in 2020
Figure 14. Global Top Bacterial Vaginosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Treatment Revenue in 2020
Figure 16. Global Bacterial Vaginosis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Bacterial Vaginosis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bacterial Vaginosis Treatment Market Share by Type (2016-2027)
Figure 20. North America Bacterial Vaginosis Treatment Market Share by Application (2016-2027)
Figure 21. North America Bacterial Vaginosis Treatment Market Share by Country (2016-2027)
Figure 22. United States Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bacterial Vaginosis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Bacterial Vaginosis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Bacterial Vaginosis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bacterial Vaginosis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bacterial Vaginosis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bacterial Vaginosis Treatment Market Share by Region (2016-2027)
Figure 38. China Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bacterial Vaginosis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Bacterial Vaginosis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Bacterial Vaginosis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bacterial Vaginosis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bacterial Vaginosis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bacterial Vaginosis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bacterial Vaginosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bayer Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 59. Lupin Inc Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 62. Piramal Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 64. Galderma Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 65. Mission Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 66. Alkem Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 67. Xiuzheng Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 68. Teva Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 69. Perrigo Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 70. West-Ward Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 71. HPGC Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 72. Yunnan Baiyao Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 73. Starpharma Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 74. Novel Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 75. Edenvridge Revenue Growth Rate in Bacterial Vaginosis Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の細菌性膣炎治療薬市場規模・現状・予測（2021年-2027年） Bacterial vaginosis is an infection characterised by overgrowth of anaerobic bacteria in the vagina with an accompanying loss of lactobacilli. Market Analysis and Insights: Global Bacterial Vaginosis Therapeutics Market The global Bacterial Vaginosis Therapeutics market size is projected to reach US…- 細菌性膣炎治療薬のグローバル市場2021 Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 201…
- 世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年） Multidrug-resistant bacteria (MDROS), also known as multidrug-resistant microorganisms, are the result of bacterial variation and excessive use of antimicrobial agents. Market Analysis and Insights: Global Multiple Drug Resistance Bacterial Infection Treatment Market The global Multiple Drug Resista…
- 世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年） According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic …
- 世界のグラム陰性菌感染症治療薬市場規模・現状・予測（2021年-2027年） Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction. Market Analysis and Insights: Global Gram-Negative Bacterial Infection Therapeutics Market The global Gram-Negative Bacterial Infection Therapeutics market size is projected to reach US$ XX milli…